Bowes Eric (46 results)

Soft cover. Condition: Near Fine. 1st Edition. First edition, first printing of this collection of one novelet and seven short stories. Featured are Testament by Valerie Freireich (novelet), A Beggar at the Bridge by Richard Bowes (short story), The Last Resort by Kit Reed (short story), Susan by Harlan Ellison (short story), Piano Pony by Ron Savage (short story), The Negotiator by Laurel Winter (short story), Faith and Friendship in the Pre-Atomic Age by Eric T Baker (short story) and Litlins by Jack Williamson ( short story). Slight edgewear. In Near Fine Condition.

Hardcover. Condition: Used. Dust Jacket Condition: Very Good. Ferguson, Michael (illustrator). First Edition. Inscribed by authors on Front Endsheet. Looks unread. First edition. Signed By Author.

SingleIssueMagazine. Condition: Good. Vol. 85, No. 6. Edited by Kristine Kathryn Rusch. Cover art by Jacek Jerka for "Susan" by Harlan Ellison. Includes "Testament" (novelet) by Valerie Freireich; "A Beggar at the Bridge" by Richard Bowes; "The Last Resort" by Kit Reed; "Piano Pony" by Ron Savage; "The Negotiator" by Laurel Winter; "Faith and Friendshiop in the Pre-Atomic Age" by Eric T. Baker; "The Litlins" by Jack Williamson. Departments: "Books: Forward Into the Past" by "Books to Look For" by Orson Scott Card; "Science: Aliens We Can Know" by Gregory Benford; "F*SF Competition"; "Index to Volume 85". Label pulls and remains to front (see scan); creasingminro edge tears, bumps and dings. Book.

Condition: New. Ferguson, Michael (illustrator).

Paperback. Condition: Near Fine. Color, b/w ilIustrations (illustrator). First Edition. Catalogue of the gallery's exhibition, issued in an edition of 2000 copies. [20] pages. Slight wear; minor staining to edges. Size: 4to - over 9¾" - 12" tall. Ephemera.

Hardcover. Condition: Very Good. Dust Jacket Condition: Very Good. Baha'i Publishing Trust, 1958. Book has light foxing/smudges to textblocks, mild smudges to top edges, faint rubbing and tiny smudges to covers, light wear to corners. otherwise in very good condition, strong binding, clean and unmarked pages; an overall sturdy copy. Dust jacket has mild rubbing to front/back with fading to spine, scuffs to edges and corners, a .6 inch tear to front side top edge. in very good condition, now in archival cover.

Hardcover. Condition: Near Fine. Dust Jacket Condition: Very Good +. First Edition. 83pp.; HB yellow w/blk.; slight rub w/clean,tight pgs. DJ yellow w/blk&white; some rub; spine sunned; 1"chip bk.cover; sml.chips&tears. Essays, originally lectures in a Congregational church in Australia discussing great moments in Biblical past. some illus.

vg+/vg, prev owner name, dj lite edgewear, o/w bright & tight. size approx 5x7 with 83 pages. Illustrated by photographs. 1st printing edition. Binding is yellow cloth.

Paperback. Condition: Acceptable.

Paperback. Condition: New. 2nd ed.

Hard Cover. Condition: Good. Dust Jacket Condition: Good. First Edition. some wear covers, clear adhesive cover, some moisture staining, otherwise clean and tight Size: 12mo - over 6¾" - 7¾" tall.

Pamphlet. Very good in wrappers.

Paperback. Condition: New. 2nd ed.

Paperback. Condition: New. 2nd ed.

Hardcover. Condition: Gut. 1st ed. 235x155 mm. Erste Auflage, 144 p. plus 96 p. of plates. Hardcover, white, with gilt letters on spine, dust jacket. Sprache: Englisch, Numerous ill. on plates, b/w. Good condition. Slight yellowing of pages. Dustjacket with discrete rips and yellowing. Clean inside. USADO / GEBRAUCHT / USED. Frontispiece: Tiepolo, the harnessing of the horses of the sun. [Paintings 16th to 18th Century+Bowes Museum+Catalogue+Spanish and Italian paintings+County Durham]. ** 10% DESCUENTO/RABATT/DISCOUNT PRIMAVERA * excl. New German Books * * * * 21,60 (original price 24,00) **.

Paperback. Condition: New. 2nd ed.

Condition: New.

Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condition: New.

Condition: New.

Condition: New. In.

Condition: New. In.

Condition: New.

Gebunden. Condition: New.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. Most blinding [CG1] diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.Significant advances in these areas of retinal degenerations have been made since the last RD Symposium, RD2021. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2023 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. Most blinding [CG1]diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.Significant advances in these areas of retinal degenerations have been made since the last RD Symposium, RD2021. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2023 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

Condition: New.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that withsuccessful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that withsuccessful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

Hardcover. Condition: Brand New. 538 pages. 10.00x7.00x10.00 inches. In Stock.